<DOC>
	<DOCNO>NCT02932267</DOCNO>
	<brief_summary>This multicenter open-label , prospective study subject dark skin one 3 ethnic/race background : Asian , Latin American Black/African-American moderate severe acne vulgaris face . All eligible subject receive Adapalene 0.3 % - BPO 2.5 % gel ( Epiduo Forte/TactuPump Forte ) daily whole face . The purpose trial evaluate subject report outcomes combination Adapalene 0.3 % - BPO 2.5 % , Epiduo Forte / TactuPump Forte gel , 16 week treatment moderate severe acne dark skin phototypes ( IV VI ) .</brief_summary>
	<brief_title>Subject Reported Outcomes With Use Adapalene 0.3 % - Benzoyl Peroxide ( BPO ) 2.5 % Dark Skin Acne</brief_title>
	<detailed_description />
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Adapalene</mesh_term>
	<mesh_term>Benzoyl Peroxide</mesh_term>
	<criteria>Subject clinical diagnosis moderate severe facial acne vulgaris , define : 1 . Investigator 's Global Assessment ( IGA ) score 3 ( Moderate ) OR 4 ( Severe ) ; 2 . A minimum 25100 inflammatory lesion ( papule pustule ) ; 3 . A minimum 30150 noninflammatory lesion ( open close comedo ) total ( exclude nose ) ; 4 . No two acne nodule ( â‰¥ 1 cm ) , Subject skin phototype IV VI Fitzpatrick skin phototype scale , Subjects one 3 ethnic/race background : Asian , Latin American Black/AfricanAmerican , Subject acne conglobata , acne fulminans , secondary acne ( chloracne , druginduced acne , etc . ) , nodulo cystic acne , acne require systemic treatment , Subject history lupus , atopic dermatitis , perioral dermatitis , dermatomyositis , rosacea Female subject pregnant , lactate plan pregnancy trial , Subjects receive least one follow topical treatment treat area : Corticosteroids , antibiotic , benzoyl peroxide , azelaic acid , dapsone , hydroxyacids , Zinc contain treatment , antiseptic , antiinflammatory product acne treatment ( 2 week ) ; Retinoids ( 4 week ) ; Cosmetic/aesthetic procedure face ( 1 week ) ; Wax epilation ( 2 week ) ; Photodynamic therapy ( 6 week ) ; Laser therapy , microdermabrasion , deep chemical peel , plastic surgery acne ( 3 month ) . Subjects receive least one follow systemic treatment : Corticosteroids , tetracycline , antibiotic ( except penicillin ) ( 1 month ) ; Oral retinoids/isotretinoin/ antiandrogens / Cyproterone acetate / Chlormadinone acetate ( 6 month ) ; Spironolactone/ Drospirenone ( 3 month ) ; Immunomodulators ( 3 month ) Oral contraceptives/ oral dapsone acne ( 1 month ) .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Acne</keyword>
	<keyword>Dark skin</keyword>
</DOC>